Abstract
Rheumatoid arthritis is a systemic chronic inflammatory disease characterized by multi-articular inflammation that causes bone erosion and joint dysfunction. At present, biological and synthetic disease-modifying antirheumatic drugs (DMARDs) are available for its treatment. With these patients, the objective is to achieve remission or, if not that, a low level of disease activity, following the treat-to-target strategy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Medicine - Programa de Formación Médica Continuada acreditado
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
